newsfilter
← Latest News
GlobeNewswire·

Codex DNA Announces Commercial Availability of Automated mRNA Synthesis Kit with Integrated Capping Technology for BioXp™ System

Proven CleanCap® reagent technology from TriLink BioTechnologies delivers significant time and cost savings for mRNA-based vaccine and therapeutic applications Codex DNA scientists to share latest data and showcase mRNA synthesis solutions at upcoming